Hans Vitzthum | LifeSci Advisors |
Raj Kannan | CEO & Director |
Michelle Senchyna | Head, Clinical Development and Medical Affairs |
Jeffrey Calabrese | Director, Accounting |
François Brisebois | Oppenheimer |
Louise Chen | Cantor Fitzgerald & Co. |
Stacy Ku | Cowen and Company |
Annabel Samimy | Stifel, Nicolaus & Company |
Serge Belanger | Needham & Company |
Carly Kenselaar | Citigroup |
Jason Gerberry | Bank of America Merrill Lynch |
Gregory Fraser | Truist Securities |
Good afternoon. Thank you for standing by, and welcome to the Aerie Pharmaceuticals Fourth Quarter and Full Year 2021 Earnings Conference Call. [Operator Instructions]. Today's conference will be recorded. It is now my pleasure to turn the floor over to Hans Vitzthum of LifeSci Partners, Aerie's Investor Relations firm.